Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Sam Altman and Arianna Huffington’s AI Health Revolution

by Team Lumida
July 9, 2024
in AI, Health and Longevity
Reading Time: 3 mins read
A A
0
Sam Altman and Arianna Huffington’s AI Health Revolution

Source: Decrypt

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  • OpenAI and Thrive Global launch Thrive AI Health to extend health spans.
  • AI health coach offers personalized advice using biometrics and lifestyle data.
  • Partnership focuses on health equity, targeting underserved populations.

What Happened?

OpenAI’s Sam Altman and Thrive Global’s Arianna Huffington announced the launch of Thrive AI Health, a new initiative aimed at revolutionizing healthcare using artificial intelligence. Thrive AI Health will develop an AI health coach offering personalized recommendations based on biometrics and lifestyle habits.

The platform will integrate Thrive’s behavior change methodology, focusing on microhabit changes. DeCarlos Love, a former Google executive, will lead as CEO. The Alice L. Walton Foundation supports this venture, and key partnerships include Stanford Medicine and the Rockefeller Neuroscience Institute.

Why It Matters?

AI in healthcare promises to address critical issues like chronic disease management and health equity. With 130 million Americans diagnosed with chronic conditions, Thrive AI Health aims to provide tailored health recommendations, potentially reducing the prevalence of chronic diseases and improving quality of life.

As Arianna Huffington emphasized, AI can democratize access to health benefits, similar to how the New Deal transformed physical infrastructure. By leveraging AI, Thrive AI Health could offer scalable, precise health interventions that human coaches cannot match.

What’s Next?

The inaugural team at Thrive AI Health is moving swiftly to customize and test the AI health coach. They plan to make the product available to Thrive Global’s employer base and expand through self-insured employers and pharmaceutical companies. As they scale, the focus will remain on maintaining robust privacy and security measures.

Partnerships with academic institutions will further aid in refining and validating the AI coach’s effectiveness. Investors and stakeholders should watch for how this platform could become integral to future health infrastructure, especially in underserved communities.

Source: Fortune Well
Tags: AI health coachArianna HuffingtonSam Altman
Previous Post

Bullish Bitcoin: Why Market Experts Predict a Major BTC Comeback

Next Post

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Recommended For You

Xi Endorses Open-Source AI at Shanghai Conference, Casting China as Champion of Openness Against US Chip and Model Restrictions

by Team Lumida
12 hours ago
China’s Bold Economic Moves: What You Need to Know Now

Chinese President Xi Jinping endorsed open-source AI development at the World AI Conference in Shanghai, framing China as a champion of openness and equality — an implicit critique...

Read more

AI Executives Are Facing Real-World Violence — Altman’s Home Firebombed, Anthropic Lobby Breached as Tech Backlash Turns Physical

by Team Lumida
2 days ago
AI Investment Boom: How Tech Giants Are Leading the Charge

Violent threats against AI companies are escalating from online abuse into real-world security incidents: an attempted firebombing of OpenAI CEO Sam Altman's home was captured on surveillance video...

Read more

Anthropic Targets October IPO — $965 Billion Valuation Would Make It the Largest Tech Debut Since the AI Era Began

by Team Lumida
2 days ago
Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic PBC is scheduling investor meetings with banks Morgan Stanley, Goldman Sachs, and JPMorgan ahead of a potential IPO as soon as October 2026 — which would put...

Read more

$399 Signal Ring Claims to Replace the Blood Pressure Cuff — No Calibration, No Subscription, Clinical Trial at Stanford

by Team Lumida
2 days ago
Fingers hold a black smart ring with circuits visible.

Vital Signals, a three-year-old startup, has launched a $399 Signal Ring that claims to track blood pressure as accurately as a traditional arm cuff — without requiring any...

Read more

AI Chips as Diplomatic Currency: UAE Gets Expanded Nvidia Access in Exchange for Carrying Out Dozens of Iran Airstrikes

by Team Lumida
3 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

The UAE gained expanded US access to advanced AI chips after aiding America in the Iran war — conducting dozens of airstrikes on Iranian targets, intercepting hundreds of...

Read more

Novo’s Obesity Pill Commands 89% Market Share — Lilly’s Foundayo Captures Just 11% After Three Months on Market

by Team Lumida
3 days ago
Novo’s Obesity Pill Commands 89% Market Share — Lilly’s Foundayo Captures Just 11% After Three Months on Market

Novo Nordisk's Wegovy pill has seized 89% of new oral obesity pill prescriptions since its January 2026 launch, leaving Eli Lilly's Foundayo — launched in April — with...

Read more

IBM Loses $69 Billion in One Day — The SaaS-pocalypse Is Here as Enterprise AI Spending Crowds Out Software Budgets

by Team Lumida
3 days ago
IBM logo

IBM shares fell more than 25% Tuesday — the largest single-day decline in the company's history — after management warned that enterprise customers are shifting spending from software...

Read more

Data Center Developers Are Racing to Cash Out: Majority Stakes Worth Tens of Billions Hit the Market This Summer

by Team Lumida
4 days ago
brown wooden hallway with gray metal doors

America's data center developers — who built the physical infrastructure of the AI boom — are working with bankers this summer to sell majority equity stakes worth tens...

Read more

Nvidia Partner GMI Cloud Seeks $635 Million GPU-Backed Loan — One of Asia’s First Syndicated AI Infrastructure Financings

by Team Lumida
4 days ago
Nvidia CEO Reveals Secrets Behind AI Domination Amidst Fierce Competition

GMI Cloud, a US-based Nvidia cloud partner backed by Taiwan's GMI Technology and Realtek Semiconductor, is seeking a NT$20.45 billion ($635 million) bank loan supported by GPU computing...

Read more

DeepSeek’s Liang Wenfeng Is Now Worth $36 Billion — Richer Than Dario Amodei and Greg Brockman Combined

by Team Lumida
4 days ago
A close up of a cell phone with a keyboard

DeepSeek founder Liang Wenfeng's net worth more than doubled to $36 billion after the startup's $7.4 billion June funding round valued the company at $50 billion — a...

Read more
Next Post
low angle photo of city high rise buildings during daytime

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Man on his Surface laptop at home with Christmas decorations around

AI PCs: The Future of Computing or Just Hype?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Fed Official Warns of Inflation Risks Under Trump Presidency

Fed Official Warns of Inflation Risks Under Trump Presidency

January 4, 2025
Warren Buffett’s Berkshire Sells Major Bank of America Stake – Implications for Your Portfolio

Berkshire Trims Apple, Buys UnitedHealth; Boosts Cash to Record $344 Billion

August 15, 2025
Vance Says Iran Is Ignoring Core US Demands, Setting Two-Week Deadline to Bridge Nuclear Deal Gaps

Vance Says Iran Is Ignoring Core US Demands, Setting Two-Week Deadline to Bridge Nuclear Deal Gaps

February 18, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018